Cargando…

Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

PURPOSE: The present study evaluated how heart failure (HF) negatively impacts health-related quality of life (HRQoL) in hypertrophic cardiomyopathy (HCM) patients and explored the major clinical determinants associated with HRQoL impairment in this population. METHODS: This was a cross-sectional si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capota, Razvan, Militaru, Sebastian, Ionescu, Alin Alexandru, Rosca, Monica, Baicus, Cristian, Popescu, Bogdan Alexandru, Jurcut, Ruxandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602300/ https://www.ncbi.nlm.nih.gov/pubmed/33126893 http://dx.doi.org/10.1186/s12955-020-01604-9

Ejemplares similares

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy – a case report
por: Giucă, Adrian, et al.
Publicado: (2020)

Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
por: dos Reis, Mariane Cecilia, et al.
Publicado: (2023)

Sclerodermic Cardiomyopathy—A State-of-the-Art Review
por: Giucă, Adrian, et al.
Publicado: (2022)

The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2020)

Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire
por: Spertus, John A., et al.
Publicado: (2015)

Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients
por: Spertus, John A., et al.
Publicado: (2007)

Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure
por: Albarrati, Ali M., et al.
Publicado: (2023)

New Fabry disease mutation confirms cardiomyopathy aetiology: a case report
por: Militaru, Sebastian, et al.
Publicado: (2018)

New York Heart Association Class and Kansas City Cardiomyopathy Questionnaire in Acute Heart Failure
por: Huo, Xiqian, et al.
Publicado: (2023)

Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock’s clinical score in predicting heart failure outcomes
por: Sawadogo, Kiswendsida, et al.
Publicado: (2015)

Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure
por: Watanabe-Fujinuma, Emi, et al.
Publicado: (2020)

Kansas City Cardiomyopathy Questionnaire Utility in Prediction of 30-Day Readmission Rate in Patients with Chronic Heart Failure
por: Dai, Shengchuan, et al.
Publicado: (2016)

Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
por: Tummalapalli, Sri Lekha, et al.
Publicado: (2020)

High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy
por: Chivulescu, Monica, et al.
Publicado: (2020)

Current challenges for using the Kansas City Cardiomyopathy Questionnaire to obtain a standardized patient‐reported health status outcome
por: Stogios, Nicolette, et al.
Publicado: (2021)

Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis
por: Coles, Theresa M., et al.
Publicado: (2022)

Adapting and usability testing of the Kansas city cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in Tanzania: the Swahili KCCQ
por: Chillo, Pilly, et al.
Publicado: (2023)

Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure
por: Mattsson, Gustav, et al.
Publicado: (2021)

Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression
por: Popa-Fotea, Nicoleta Monica, et al.
Publicado: (2019)

Acute Myocarditis-Like Episode in a Curly-Haired Young Boy—Red Flags for Familial Arrhythmogenic Cardiomyopathy
por: Pătru, Alina Elena, et al.
Publicado: (2020)

Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire
por: Ravera, Alice, et al.
Publicado: (2021)

Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy
por: Micheu, Miruna Mihaela, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire
por: Shiraishi, Yasuyuki, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
por: Achim, Alexandru, et al.
Publicado: (2023)

Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?
por: Caraiola, Simona, et al.
Publicado: (2023)

Kansas City
Publicado: (1896)

Kansas City
Publicado: (1896)

Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy
por: Rosu, Radu Ovidiu, et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets
por: Hunger, Matthias, et al.
Publicado: (2020)

Takotsubo Cardiomyopathy in a Patient with Preexisting Hypertrophic Cardiomyopathy
por: Elhosseiny, Sherif, et al.
Publicado: (2018)

The Many Lives of a Complex Marfan Syndrome Patient: Staged Therapeutic Decisions
por: Militaru, Cristian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvgtufuhvnb0cb8bgntiqugdnm